
[ Thu, Mar 31st 2022 ]: WOPRAI
[ Thu, Mar 31st 2022 ]: WOPRAI
[ Thu, Mar 31st 2022 ]: WOPRAI
[ Thu, Mar 31st 2022 ]: WOPRAI
[ Thu, Mar 31st 2022 ]: WOPRAI
[ Thu, Mar 31st 2022 ]: WOPRAI
[ Thu, Mar 31st 2022 ]: WOPRAI
[ Thu, Mar 31st 2022 ]: WOPRAI
[ Thu, Mar 31st 2022 ]: WOPRAI
[ Thu, Mar 31st 2022 ]: WOPRAI
[ Thu, Mar 31st 2022 ]: WOPRAI
[ Thu, Mar 31st 2022 ]: WOPRAI
[ Thu, Mar 31st 2022 ]: WOPRAI
[ Thu, Mar 31st 2022 ]: WOPRAI
[ Thu, Mar 31st 2022 ]: WOPRAI
[ Thu, Mar 31st 2022 ]: WOPRAI
[ Thu, Mar 31st 2022 ]: WOPRAI
[ Thu, Mar 31st 2022 ]: WOPRAI
[ Thu, Mar 31st 2022 ]: WOPRAI
[ Thu, Mar 31st 2022 ]: WOPRAI
[ Thu, Mar 31st 2022 ]: WOPRAI
[ Thu, Mar 31st 2022 ]: WOPRAI
[ Thu, Mar 31st 2022 ]: WOPRAI
[ Thu, Mar 31st 2022 ]: WOPRAI
[ Thu, Mar 31st 2022 ]: WOPRAI
[ Thu, Mar 31st 2022 ]: WOPRAI
[ Thu, Mar 31st 2022 ]: WOPRAI
[ Thu, Mar 31st 2022 ]: WOPRAI
[ Thu, Mar 31st 2022 ]: WOPRAI
[ Thu, Mar 31st 2022 ]: WOPRAI
[ Thu, Mar 31st 2022 ]: WOPRAI
[ Thu, Mar 31st 2022 ]: WOPRAI
[ Thu, Mar 31st 2022 ]: WOPRAI
[ Thu, Mar 31st 2022 ]: WOPRAI
[ Thu, Mar 31st 2022 ]: WOPRAI
[ Thu, Mar 31st 2022 ]: WOPRAI
[ Thu, Mar 31st 2022 ]: WOPRAI
[ Thu, Mar 31st 2022 ]: WOPRAI
[ Thu, Mar 31st 2022 ]: WOPRAI
[ Thu, Mar 31st 2022 ]: WOPRAI
[ Thu, Mar 31st 2022 ]: WOPRAI
[ Thu, Mar 31st 2022 ]: WOPRAI
[ Thu, Mar 31st 2022 ]: WOPRAI
[ Thu, Mar 31st 2022 ]: WOPRAI
[ Thu, Mar 31st 2022 ]: WOPRAI
[ Thu, Mar 31st 2022 ]: WOPRAI
[ Thu, Mar 31st 2022 ]: WOPRAI
[ Thu, Mar 31st 2022 ]: WOPRAI
Ed Arce Downgraded (AKBA) to Hold and Decreased Target to $2 on, Mar 31st, 2022


🞛 This publication is a summary or evaluation of another publication
Ed Arce of HC Wainwright & Co., Downgraded "Akebia Therapeutics, Inc." (AKBA) to Hold and Decreased Target from $10 to $2 on, Mar 31st, 2022.
Ed, nor any peers, have made any analyst calls on AKBA in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30